No serotonin 5-HT(2A) receptor density abnormality in the cortex of schizophrenic patients studied with PET

Schizophrenia Research

Volumn 31, Issue 1, 1998, Pages 13-17

  Trichard, Christian ^a,b   Paillère Martinot, Marie Laure ^c   Attar Levy, Dominique ^d   Blin, Jérome ^c   Feline, André ^e   Martinot, Jean Luc ^a,e,f  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b CENTRE HOSPITALIER DE GONESSE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d CENTRE HOSPITALIER SAINTE ANNE   (France)

^e BICÊTRE HOSPITAL   (France)

^f Hopital Albert Chenevier   (France)

Author keywords

5 HT(2A) receptor; PET; Schizophrenia

Indexed keywords

SEROTONIN 2A RECEPTOR; SETOPERONE; DIAGNOSTIC AGENT; PYRIMIDINONE DERIVATIVE; SEROTONIN RECEPTOR;

ADULT; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; ISOTOPE LABELING; LIGAND BINDING; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; SCHIZOPHRENIA; SUICIDE; CELL COUNT; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEMISPHERIC DOMINANCE; METABOLISM; SCINTISCANNING;

ADULT; CELL COUNT; CEREBRAL CORTEX; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; PYRIMIDINONES; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032481931     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00014-0     Document Type: Article

References (24)

1. Arora, R.C., Meltzer, H.Y., 1991. Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients. J. Neural. Transm. Gen. Sect. 85, 19-29.
2. Bennett, J.P., Enna, S.J., Bylund, D.B., Gillin, J.C., Wyatt, R.J., Snyder, S.H., 1979. Neurotransmitter receptors in frontal cortex of schizophrenics. Arch. Gen. Psychiatry 36, 927-934.
3. 18F-labeled setoperone. J. Neurochem. 54, 1744-1754.
4. 18F]setoperone. J. Label. Comp. Radiopharmacol. 25, 403-414.
5. Goyer, P.F., Berridge, M.S., Morris. E.D., Semple, W.E., Compton-Toth, B.A., Schulz, S.C., Wong, D.F., Miraldi, F., Meltzer, H.Y., 1996. PET measurements of neuroreceptor occupancy by typical and atypical neuroleptics. J. Nucl. Med. 37, 1122-1127.
6. Green, A.R., Johnson, P., Mountford, A., Nimgaonkar, V.L., 1985. Some anticonvulsive drugs alter monoamine-mediated behavior in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy. Br. J. Pharmacol. 84, 337-346.
7. Gross-Isseroff, R., Salama, D., Israeli, M., Biegon, A., 1990. Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem. Brain Res. 519, 223-227.
8. Joyce, J.N., Shane, A., Lexow, N., Winokur, A., Casanova, M.F., Kleinman, J.E., 1993. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8, 315-336.
9. Lamelle, M., Abi-Dargham, A., Casanova, M.F., Toti, R., Weinberger, D.R., Kleinman, J.E., 1993. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A post-mortem study. Arch. Gen. Psychiatry 50, 810-818.
10. 2, histamine-H1 antagonists, and opiates. 1986. Drug Dev. Res. 8, 119-131.
11. Leysen, J.E., Van Gompel, P., de Chaffoy de Courcelles, D., Niemegeers, C.J.E., 1987. Opposite regulation of serotonin-S2 and dopamine-D2 receptors in rat brain following chronic receptor blockade. J. Recept. Res. 7, 223-239.
12. Marcusson, J., Morgan, D., Winblad, B., Finch, C., 1984. Serotonin-2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age. Brain Res. 311, 51-56.
13. 2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology 133, 99-101.
14. 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors. Nucl. Med. Biol. 15, 463-468.
15. Middlemiss, D.N., Hibert M., Fozard, J.P., 1986. Drugs acting at central 5-hydroxytryptamine receptors. In: Bailey, D.M. (Ed.), Annual Reports in Medicinal Chemistry. Academic Press. San Diego, pp. 41-50.
16. Mintun, M., Raichle, M., Kilbourn, M., Wooten, G., Welch, M., 1984. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann. Neurol. 15, 217-227.
17. Mita, T., Hanada, S., Nishino, N., Kuno, T., Nakai, H., Yamadori, T., Mizoi, Y., Tanaka, C., 1986. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol. Psychiatry 21, 1407-1414.
18. 2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am. J. Psychiatry 152, 1444-1449.
19. Nyberg, S., Farde, L., Eriksson, L., Halldin, C., Eriksson, B., 1993, 5-HT2 and D2 dopamine receptor occupancy in the living human brain. Psychopharmacology 110, 265-272.
20. Reynolds, G., Rossor, M.N., Iversen, L.L., 1983. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. J. Neural. Transm. 18 (Suppl.), 273-277.
21. Soussaline, F., Campagnolo, R., Verrey, B., Bendriem, B., Bouvier, A., Lecomte, J., Comard, D., 1984. Physical characterization of a time of flight positron emission tomography system for whole body quantitative studies. J. Nucl. Med. 25, 46
22. 2A receptors: a PET study in schizophrenics with chlorpromazine, clozapine and amisulpride. Am. J. Psychiatry.
23. Wagner, H.R., Reches, A., Yablonskaya, E., Fahn, S., 1986. Clonazepam-induced up-regulation of serotoninl and serotonin2 binding sites in rat frontal cortex. In: Fahn, S., Marsden, D., Van Woert, M. (Eds.). Advances in Neurology, vol. 43: Myoclonus. Raven Press, New York, pp. 645-651.
24. Whitaker, P.M., Crow, T.J., Ferner, I.N., 1981. Tritiated LSD binding in frontal cortex in schizophrenia. Arch. Gen. Psychiatry 38, 278-280.